Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Henagliflozin for Weight Loss in Obesity Without Diabetes
NCT06216340Phase 4Not yet recruiting
- Sponsor
- Changzhou First People's Hospital
- Start
- Feb 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of henagliflozin in obesity, sponsored by Changzhou First People's Hospital. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
henagliflozin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06216340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06216340.